Johnson & Johnson pulls out of HIV phase III trial
Johnson & Johnson stopped the phase III trial of its global HIV vaccine trial after it found that the regimen was ineffective in.
Drugs
Pharma
Drugs
Pharma
India bolsters regulators to brace global competition
India is bolstering its regulatory bodies to global standards to become a world leader in drug discovery and innovative medical devices, a minister.
Drugs
Pharma
Glenmark’s heart failure treatment drug makes India debut
Glenmark Pharmaceuticals, an Indian multinational firm, has introduced its heart failure drug in the country, according to a company statement.
Drugs
Pharma
US regulatory nod for Lupinās HIV drug in the works
Pharma major Lupin has received a ātentative approvalā, from the United States Food and Drug Administration (FDA), to market medicines used to treat.
Drugs
Pharma
USFDA grants ātentative approvalā to Zydusā mental health drug
The USFDA has granted Zydus Lifesciences Limited ātentative approvalā to market Levomilnacipran extended-release capsules in 20 mg, 40 mg, 80 mg, and 120.
Drugs
Pharma
Eiasi files market authorization for Alzheimer’s drug in Japanļæ¼
Eiasi Co., a Japanese pharmaceutical company, has submitted a marketing authorization application for a drug, lacanemab, to treat Alzheimer's disease.
Drugs
Health
Pharma
Decade-long study pinpoints baffling causes of epilepsy in children
he current treatment of cortical malformations in the anterior parts of the brain, or cerebrum, in vertebrates by its surgical removal to cure.
Drugs
Medical
Pharma
UKās AI stroke machine to cut treatment time by 60 mts
An artificial intelligence-powered machine can reduce the treatment time for stroke patients by 60 minutes and free up cliniciansā time.
Drugs
Health
AAP guidelines for obesity treatment in children call for early, intensive treatment
The American Academy of Pediatrics has issued guidelines advising aggressive treatment of obesity in children as young as 12.